✦ LIBER ✦

DRUG SAFETY IN PORPHYRIA: RISKS OF VALPROATE AND METOCLOPRAMIDE

✍ Scribed by Dos, Manfred; Becker, Ulrike; Peter, Hermann-Jörg; Kaffarnik, Hans

Book ID: 123384706
Publisher: The Lancet
Year: 1981
Tongue: English
Weight: 171 KB
Volume: 318
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(81)90440-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

RISKS OF VALPROATE IN PORPHYRIA

✍ GARCIAMERINO, J 📂 Article 📅 1980 🏛 The Lancet 🌐 English ⚖ 167 KB

The Safety Risks of InnovationThe FDA's

The Safety Risks of InnovationThe FDA's Expedited Drug Development PathwayThe Safety Risks of Innovation in Drug Development

✍ Moore, Thomas J. 📂 Article 📅 2012 🏛 American Medical Association 🌐 English ⚖ 50 KB

Safety of vancomycin in acute porphyria.

✍ R Hift; U Sohnius; PN Meissner 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB

Carbamazepine and valproate monotherapy:

Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder

✍ Kamini Vasudev; U. Goswami; Kamlesh Kohli 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 87 KB

Impact of Regulatory Guidances and Drug

Impact of Regulatory Guidances and Drug Regulation on Risk Minimization Interventions in Drug Safety

✍ Lenhangmbong Nkeng, Anne-Marie Cloutier, Camille Craig, Jacques Lelorier, Dr Yol 📂 Article 📅 2012 🏛 Springer International Publishing AG 🌐 English ⚖ 161 KB

Drugs During Pregnancy and Lactation ||

Drugs During Pregnancy and Lactation || Table 1 Risk and safety of medicinal drugs

✍ , 📂 Article 📅 2007 🏛 Elsevier ⚖ 53 KB